"Novel targeted therapy combinations to improve efficacy in BRAF and KRAS mutant cancers," Ryan Corcoran, MD, PhD

Thursday, January 3, 2013 at 3:00pm to 4:00pm

Dana-Farber Cancer Institute, Dana 1620 Dana-Farber Cancer Institute, Boston, MA, Boston, MA

The DFCI Division of Molecular and Cellular Oncology presents a special seminar by Ryan Corcoran. His talk is titled "Novel targeted therapy combinations to improve efficacy in BRAF and KRAS mutant cancers"

Share
Subscribe
Event Type

Basic Science, Clinical Research

Hashtag

#novel_targeted_therapy_combinations_to_improve_efficacy_in_braf_and_kras_mutant_cancers_ryan_corcoran_md_phd

Recent Activity

People Going

Getting Here

Event Registration Required

This event requires registration.


NCI CCC